You have 9 free searches left this month | for more free features.

Ph

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

pH Trial in Santa Monica (ConcenTrace)

Active, not recruiting
  • pH
  • ConcenTrace
  • Santa Monica, California
    Citruslabs
Nov 2, 2023

Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)

Not yet recruiting
  • Squamous Cell Carcinoma of the Skin
  • +2 more
  • Marlborough, Massachusetts
    Phio Pharmaceuticals Corp.
Aug 25, 2023

Esophageal pH-MIIduration: 12 or 24 Hours?

Recruiting
  • Gastro Esophageal Reflux
  • multichannel intraluminal impedance and pH monitoring (MII/pH)
  • Roma, Italy
    Fondazione Policlinico Gemelli IRCCS
Feb 27, 2023

Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Trial in Xi'an (Olverembatinib plus venetoclax and dexamethasone)

Recruiting
  • Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
  • Olverembatinib plus venetoclax and dexamethasone
  • Xi'an, Shannxi, China
    Department of Hematology, Xijing Hospital, Fourth Military Medic
Oct 9, 2023

Healthy Trial in Fort Wayne (Listerine Experimental Mouthwash, Colgate Cavity Protection Toothpaste, Listerine Total Care Zero)

Completed
  • Healthy
  • Listerine Experimental Mouthwash
  • +3 more
  • Fort Wayne, Indiana
    Salus Research, Inc.
Aug 23, 2023

Child, Saliva, Dental Plaque Trial in Damascus (Effect of aqueous propolis gums in salivary and dental plaque pH in children,

Recruiting
  • Child
  • +2 more
  • Effect of aqueous propolis gums in salivary and dental plaque pH in children
  • Effect of placebo gums in salivary and dental plaque pH in children
  • Damascus, Syrian Arab Republic
    Damascus University
Mar 20, 2023

B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Azacitidine Injection
  • +2 more
  • (no location specified)
Oct 15, 2023

Oral Health Trial in Moscow (No intervention (negative control), Water (positive control), Dental foam "Biorepair PERIBIOMA")

Not yet recruiting
  • Oral Health
  • No intervention (negative control)
  • +4 more
  • Moscow, Russian Federation
    Institute of Dentistry of Sechenov University
Nov 20, 2023

Abnormal Fetal Heart Rate Trial in Nancy (Fetal blood sampling)

Completed
  • Abnormal Fetal Heart Rate
  • Fetal blood sampling
  • Nancy, Meurthe-et-Moselle, France
    Regional University Maternity of Nancy
Jun 12, 2023

pH-impedance Tracings According to Wingate Consensus, and

Recruiting
  • GERD
  • Questionnaires
  • Brussel, Brussels, Belgium
  • +1 more
Oct 9, 2023

Breast Cancer, HER2-positive Breast Cancer Trial in Zhengzhou (Albumin paclitaxel+trastuzumab+pyrrolitinib,

Active, not recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Zhengzhou, Henan, China
    Henan cancer hospital
Jun 23, 2023

Skin Cancer, Occupational Exposure Trial (SSW Works, Minimal Information Control)

Not yet recruiting
  • Skin Cancer
  • Occupational Exposure
  • SSW Works
  • Minimal Information Control
  • (no location specified)
Mar 7, 2023

pH, Microbiome, Dental Plaque Trial (Stevioside)

Not yet recruiting
  • pH
  • +2 more
  • (no location specified)
May 5, 2023

In Vitro Fertilisation Outcome Trial in Egypt (Transfer embryo from pH 7.20±0.02 on either Day 3 or day 5/6, Transfer embryo

Active, not recruiting
  • In Vitro Fertilisation Outcome
  • Transfer embryo from pH 7.20±0.02 on either Day 3 or day 5/6
  • +2 more
  • Assiut, Egypt
  • +5 more
Aug 13, 2022

Pulmonary Hypertension Trial in Zurich

Recruiting
  • Pulmonary Hypertension
    • Zurich, Switzerland
      Respiratory Clinic, University Hospital of Zurich
    Nov 8, 2022

    Pain, Acute Trial in Montréal (Saline spray, Lidocaine Hydrochloride)

    Completed
    • Pain, Acute
    • Saline spray
    • Lidocaine Hydrochloride
    • Montréal, Quebec, Canada
      Centre hospitalier de l'Université de Montréal
    Jan 17, 2023

    Fluid and Electrolyte Imbalance Trial in Cairo (Lactated ringer and dextrose 5%)

    Active, not recruiting
    • Fluid and Electrolyte Imbalance
    • Lactated ringer and dextrose 5%
    • Cairo, Egypt
      National Cancer institute
    Mar 31, 2023

    Approved PH-therapies RV-PA Coupling

    Recruiting
    • Pulmonary Hypertension
      • Giessen, Hesse, Germany
        Department of Internal Medicine, Justus Liebig University Giesse
      Jun 28, 2023

      Healthy Trial in Fort Wayne (Listerine Clinical Solutions Teeth Strength, Listerine Total Care Zero Alcohol Mouthwash, Listerine

      Not yet recruiting
      • Healthy
      • Listerine Clinical Solutions Teeth Strength
      • +3 more
      • Fort Wayne, Indiana
        Salus Research, Inc.
      Nov 13, 2023

      Type 2 Diabetes Trial (behavioral, device, other)

      Not yet recruiting
      • Type 2 Diabetes
      • Acceptance and Commitment Therapy
      • +2 more
      • (no location specified)
      Sep 5, 2023

      Bioequivalence Trial in Tempe, Lincoln (efgartigimod PH20 SC as a prefilled syringe presentation, efgartigimod PH20 SC as a vial

      Recruiting
      • Bioequivalence
      • efgartigimod PH20 SC as a prefilled syringe presentation
      • efgartigimod PH20 SC as a vial + syringe presentation
      • Tempe, Arizona
      • +1 more
      Apr 5, 2023

      Glioblastoma Multiforme, Glycolytic Index, Epidermal Growth Factor Receptor Trial (pH Measurement of in vivo tissue)

      Not yet recruiting
      • Glioblastoma Multiforme
      • +2 more
      • pH Measurement of in vivo tissue
      • (no location specified)
      Sep 26, 2023

      Usefulness of Wireless pH Monitoring in GERD Diagnosis

      Recruiting
      • Gastroesophageal Reflux
      • 96-hour off IBP wireless pH monitoring capsule
      • Buenos Aires, Argentina
        Hospital de Clinicas Jose de San Martin. Buenos Aires University
      Jul 7, 2022

      Acute Lymphoblastic Leukemia Trial (chidamide, Venetoclax Oral Tablet, Inotuzumab Ozogamicin)

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • (no location specified)
      Oct 19, 2023

      Ph+ ALL, Bone Marrow Transplant, Minimal Residual Disease Trial in Tianjin (the usage of Olverembatinib combined with Inotuzumab

      Not yet recruiting
      • Ph+ ALL
      • +2 more
      • the usage of Olverembatinib combined with Inotuzumab Ozogamicin
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital, Chinese Acade
      Oct 30, 2022